Does RUXOLITINIB Cause Product quality issue? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Product quality issue have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.0% of all adverse event reports for RUXOLITINIB.
21
Reports of Product quality issue with RUXOLITINIB
0.0%
of all RUXOLITINIB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Product quality issue From RUXOLITINIB?
Of the 21 reports, 2 (9.5%) resulted in death, 2 (9.5%) required hospitalization.
Is Product quality issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Product quality issue?
ETONOGESTREL (4,651)
ALBUTEROL (4,466)
TIOTROPIUM (3,821)
MOMETASONE FUROATE (3,406)
LIDOCAINE (3,126)
FLUTICASONE\SALMETEROL (2,986)
FORMOTEROL\MOMETASONE FUROATE (2,458)
FENTANYL (2,450)
NICOTINE (1,987)
EXENATIDE (1,839)
Which RUXOLITINIB Alternatives Have Lower Product quality issue Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE